Materials Required

Before beginning, ensure the following materials are available in the laboratory:

• Recombinant Human HYI Protein (SKU: rp373256)
• Sterile, nuclease-free deionized water or appropriate reconstitution buffer (e.g., PBS, pH 7.4)
• Low-protein-binding microcentrifuge tubes (1.5 mL)
• Calibrated micropipettes and sterile tips
• Vortex mixer and benchtop microcentrifuge
• Ice bucket or cooling block
• Protein quantification reagents (e.g., BCA or Bradford assay kit)
• SDS-PAGE or Western blot reagents for quality control verification
• Appropriate assay buffers for downstream applications

All buffers and labware should be sterile and endotoxin-free to minimize interference with sensitive bioassays.

Reconstitution and Storage Procedure

Follow these steps carefully to reconstitute and store the Recombinant Human HYI Protein while maintaining its activity and integrity:

1. Equilibration: Allow the lyophilized vial to equilibrate to room temperature for 10–15 minutes before opening to prevent moisture condensation on the protein powder.
2. Reconstitution: Add the recommended volume of sterile reconstitution buffer (typically deionized water or PBS, pH 7.4) slowly and dropwise along the inner wall of the vial. Gently swirl — do not vortex vigorously — to dissolve the protein completely. Refer to the Certificate of Analysis (CoA) for the specific recommended volume for your lot.
3. Centrifugation: Briefly centrifuge the reconstituted solution at low speed (≤1,000 × g, 30 seconds) to collect any residual material from the vial walls.
4. Aliquoting: Divide the reconstituted protein into single-use aliquots in low-protein-binding tubes to avoid repeated freeze-thaw cycles, which degrade protein integrity and reduce activity.
5. Short-term storage: If the protein will be used within 1–2 weeks, store aliquots at 4°C. Add a carrier protein such as 0.1% BSA if required for stability.
6. Long-term storage: Store aliquots at -20°C or -80°C for extended periods. Do not refreeze once thawed.

Note: Specific reconstitution buffer, concentration, and storage conditions may vary by lot. Always consult the product-specific Certificate of Analysis supplied with the product.

Quality Control Verification

Before using the Recombinant Human HYI Protein in critical experiments, perform the following quality control checks to confirm integrity and purity:

• Protein quantification: Determine the actual protein concentration using a BCA or Bradford colorimetric assay against a BSA standard curve. Compare the measured value against the stated concentration on the CoA.
• SDS-PAGE analysis: Run the reconstituted protein on a reducing SDS-PAGE gel. Visualize with Coomassie staining and confirm the band appears at the expected molecular weight. Verify purity by estimating the proportion of the target band relative to total lane protein.
• Western blot confirmation: For additional specificity confirmation, perform Western blot using an anti-HYI or anti-His/anti-GST tag antibody (depending on the tag used in this lot) to confirm identity.
• Activity assay (if applicable): If functional activity is critical for your application, consult the CoA for the reported activity data and replicate an appropriate enzymatic or binding assay in-house.

Document all QC results before proceeding to downstream experiments. Discard any lot showing significant degradation or unexpected band patterns.

Downstream Application Guidelines

Recombinant Human HYI Protein may be used across a range of biochemical and cell-based research applications. General guidance for common uses is provided below:

• Enzymatic activity assays: HYI (hydroxypyruvate isomerase homolog) may be evaluated for isomerase activity using appropriate substrate and detection systems. Optimize buffer composition, pH, temperature, and protein concentration empirically for each assay format.
• Protein–protein interaction studies: The recombinant protein can serve as bait or prey in pull-down assays, co-immunoprecipitation, or surface plasmon resonance (SPR) experiments to characterize binding partners.
• Antibody validation: Use the recombinant protein as a positive control antigen for ELISA, Western blot, or immunofluorescence antibody validation experiments.
• Structural studies: High-purity recombinant protein is suitable as starting material for crystallography or cryo-EM studies, subject to further purity assessment.
• Cell-based assays: When applying the protein to live cell systems, ensure endotoxin levels are within acceptable limits and confirm cell viability controls are included.

Always perform pilot experiments with a range of protein concentrations to determine optimal working conditions before committing to large-scale experiments.

Troubleshooting

If unexpected results are observed, refer to the following troubleshooting guide: